Neoplasia in the ileoanal pouch following colectomy in patients with ulcerative colitis and primary sclerosing cholangitis

Journal of Crohn's and Colitis

Volumn 8, Issue 10, 2014, Pages 1294-1299

  Imam, Mohamad H ^a   Eaton, John E ^a   Puckett, Jason S ^a   Loftus, Edward V ^a   Mathis, Kellie L ^a   Gossard, Andrea A ^a   Talwalkar, Jayant A ^a   Lindor, Keith D ^b  

^a MAYO CLINIC   (United States)

^b ARIZONA STATE UNIVERSITY   (United States)

Author keywords

Autoimmune liver disease; Colorectal cancer; Inflammatory bowel disease

Indexed keywords

ADENOCARCINOMA; ADOLESCENT; ADULT; ARTICLE; CHILD; COHORT ANALYSIS; COLITIS; COLON RESECTION; DISEASE SEVERITY; DYSPLASIA; FEMALE; FOLLOW UP; HUMAN; ILEAL POUCH ANAL ANASTOMOSIS; ILEOANAL POUCH NEOPLASIA; INTESTINE ANASTOMOSIS; INTESTINE CANCER; LOW GRADE DYSPLASIA; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MIDDLE AGED; PRIMARY SCLEROSING CHOLANGITIS; REFRACTORY COLITIS; RETROSPECTIVE STUDY; SCHOOL CHILD; TREATMENT INDICATION; TREATMENT OUTCOME; ULCERATIVE COLITIS; ANUS NEOPLASMS; CHOLANGITIS, SCLEROSING; COLITIS, ULCERATIVE; COLOSTOMY BAG; HEALTH SURVEY; ILEAL NEOPLASMS; INCIDENCE; PATHOLOGY; PROCTOCOLECTOMY; TIME; YOUNG ADULT;

ADENOCARCINOMA; ADOLESCENT; ADULT; ANUS NEOPLASMS; CHILD; CHOLANGITIS, SCLEROSING; COLITIS, ULCERATIVE; COLONIC POUCHES; FEMALE; HUMANS; ILEAL NEOPLASMS; INCIDENCE; MALE; MIDDLE AGED; POPULATION SURVEILLANCE; PROCTOCOLECTOMY, RESTORATIVE; RETROSPECTIVE STUDIES; TIME FACTORS; YOUNG ADULT;

EID: 84908231339     PISSN: 18739946     EISSN: 18764479     Source Type: Journal    
DOI: 10.1016/j.crohns.2014.03.011     Document Type: Article

References (20)

1. Bambha K., Kim W.R., Talwalkar J., Torgerson H., Benson J.T., Therneau T.M., et al. Incidence, clinical spectrum, and outcomes of primary sclerosing cholangitis in a United States community. Gastroenterology 2003, 125:1364-1369.
2. Boberg K.M., Aadland E., Jahnsen J., Raknerud N., Stiris M., Bell H. Incidence and prevalence of primary biliary cirrhosis, primary sclerosing cholangitis, and autoimmune hepatitis in a Norwegian population. Scand J Gastroenterol 1998, 33:99-103.
3. Farrant J.M., Hayllar K.M., Wilkinson M.L., Karani J., Portmann B.C., Westaby D., et al. Natural history and prognostic variables in primary sclerosing cholangitis. Gastroenterology 1991, 100:1710-1717.
4. Kaplan G.G., Laupland K.B., Butzner D., Urbanski S.J., Lee S.S. The burden of large and small duct primary sclerosing cholangitis in adults and children: a population-based analysis. Am J Gastroenterol 2007, 102:1042-1049.
5. Kingham J.G., Kochar N., Gravenor M.B. Incidence, clinical patterns, and outcomes of primary sclerosing cholangitis in South Wales, United Kingdom. Gastroenterology 2004, 126:1929-1930.
6. Wiesner R.H., Grambsch P.M., Dickson E.R., Ludwig J., MacCarty R.L., Hunter E.B., et al. Primary sclerosing cholangitis: natural history, prognostic factors and survival analysis. Hepatology 1989, 10:430-436.
7. Soetikno R.M., Lin O.S., Heidenreich P.A., Young H.S., Blackstone M.O. Increased risk of colorectal neoplasia in patients with primary sclerosing cholangitis and ulcerative colitis: a meta-analysis. Gastrointest Endosc 2002, 56:48-54.
8. Cottone M., Scimeca D., Mocciaro F., Civitavecchia G., Perricone G., Orlando A. Clinical course of ulcerative colitis. Dig Liver Dis 2008, 40(Suppl. 2):S247-S252.
9. Cima R.R., Pemberton J.H. Medical and surgical management of chronic ulcerative colitis. Arch Surg 2005, 140:300-310.
10. Navaneethan U., Shen B. Pros and cons of medical management of ulcerative colitis. Clin colon rectal surg 2010, 23:227-238.
11. Liu Z.X., Kiran R.P., Bennett A.E., Ni R.Z., Shen B. Diagnosis and management of dysplasia and cancer of the ileal pouch in patients with underlying inflammatory bowel disease. Cancer 2011, 117:3081-3092.
12. Cairns S.R., Scholefield J.H., Steele R.J., Dunlop M.G., Thomas H.J.W., Evans G.D., et al. Guidelines for colorectal cancer screening and surveillance in moderate and high risk groups (update from 2002). Gut 2010, 59:666-689.
13. Riddell R.H., Goldman H., Ransohoff D.F., Appelman H.D., Fenoglio C.M., Haggitt R.C., et al. Dysplasia in inflammatory bowel disease: standardized classification with provisional clinical applications. Hum Pathol 1983, 14:931-968.
14. Kariv R., Remzi F.H., Lian L., Bennett A.E., Kiran R.P., Kariv Y., et al. Preoperative colorectal neoplasia increases risk for pouch neoplasia in patients with restorative proctocolectomy. Gastroenterology 2010, 139:806-812. [812 e801-802].
15. Derikx L.A., Kievit W., Drenth J.P., de Jong D.J., Ponsioen C.Y., Oldenburg B., et al. Prior colorectal neoplasia is associated with increased risk of ileoanal pouch neoplasia in patients with inflammatory bowel disease. Gastroenterology 2014, 146:119-128. [e111].
16. Walker M., Radley S. Adenocarcinoma in an ileoanal pouch formed for ulcerative colitis in a patient with primary sclerosing cholangitis and a liver transplant: report of a case and review of the literature. Dis Colon Rectum 2006, 49:909-912.
17. Stahlberg D., Veress B., Tribukait B., Broome U. Atrophy and neoplastic transformation of the ileal pouch mucosa in patients with ulcerative colitis and primary sclerosing cholangitis: a case control study. Dis Colon Rectum 2003, 46:770-778.
18. Rahman M., Desmond P., Mortensen N., Chapman R.W. The clinical impact of primary sclerosing cholangitis in patients with an ileal pouch-anal anastomosis for ulcerative colitis. Int J Colorectal Dis 2011, 26:553-559.
19. Banasiewicz T., Marciniak R., Paszkowski J., Krokowicz P., Kaczmarek E., Walkowiak J., et al. Pouchitis may increase the risk of dysplasia after restorative proctocolectomy in patients with ulcerative colitis. Colorectal Dis 2012, 14:92-97.
20. Das P., Johnson M.W., Tekkis P.P., Nicholls R.J. Risk of dysplasia and adenocarcinoma following restorative proctocolectomy for ulcerative colitis. Colorectal Dis 2007, 9:15-27.